ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2026; 51(1): 74-77


Erythropoiesis resistive index in patients with chronic kidney disease on maintenance haemodialysis

Zunaisha imran, Abdul Rehman Arshad, Abdul Raheem Mujahid, Rizwan Yusuf.



Abstract
Download PDF Post

Objective: To determine factors that could predict a higher erythropoiesis resistive index (ERI) in patients on maintenance hemodialysis.
Methodology: This observational study was carried out at the Department of Nephrology, Combined Military Hospital, Lahore from September to October 2024. Patients on maintenance hemodialysis for the last three months or more were included. Patients with acute kidney injury, patients with chronic kidney disease undergoing maintenance hemodialysis for less than three months, patients frequently missing their hemodialysis sessions to an extent that they get dialyzed less than two times a week were excluded. Information about the type of vascular access, frequency and vintage of hemodialysis, presence of residual renal function (defined as urine output >100 ml/ day), and the total weekly erythropoietin dose being administered were recorded. Charlston Comorbidity Index was calculated. Hemoglobin and serum albumin levels were checked pre-dialysis. Kt/V was measured using the built-in online clearance monitoring module.
Results: There were 92 patients, aged 54.32±13.81 years. Adequate hemoglobin levels (>10 g/dL) were attained in only 33 (35.87%) patients. The median ERI was 16.26 IU/week/kg/g/dL, with an interquartile range from 12.21- 20.39. It was

Key words: Anemia, chronic kidney failure, end stage renal disease, erythropoietin, renal dialysis.





Bibliomed Article Statistics

11
25
18
14
3
R
E
A
D
S

12

37

55

38

1
D
O
W
N
L
O
A
D
S
0203040506
2026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.